Wen, Z., Lin, B., Wang, Q., Zhou, X., Liu, X., Du, X., Xu, N. (2025). Flumatinib versus nilotinib as first-line therapy for chronic myeloid leukemia in chronic Phase: A propensity score-matched cohort study. Blood. https://doi.org/10.1182/blood-2025-3776